Home › Tyrogenex X-82 Poster Presentation at the 2015 American Society for...
 

Keywords :   


Tyrogenex X-82 Poster Presentation at the 2015 American Society for...

2015-05-31 01:52:06| Logistics - Topix.net

Tyrogenex, a leader in the development of novel kinase inhibitors to target angiogenesis, today announced that the University of Wisconsin presented a new trial concept of investigational agent X-82, as a "Trials in Progress" poster at the 51st Annuali 1 2Meeting of the American Society of Clinical Oncology in Chicago. The study titled, "Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel," focuses on the optimization of a VEGFR/PDGFR TKI in combination with docetaxel.

Tags: for american society presentation

Category:Transportation and Logistics

Latest from this category

All news
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Summary for Remnants of John (EP5/EP102024)
27.09Remnants of John Public Advisory Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
Transportation and Logistics »
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
More »